Announcements Trials
Browse Landscape

Phase

Phase 2 96Phase 1 24Phase 1/2 14Phase 3 10Phase NA 6Phase 4 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1Burkitt Lymphoma 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 31Bupivacaine 31Vincristine 27Propofol 25Methotrexate 25Cisplatin 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Bevacizumab 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Idarubicin 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Carmustine × Clear all
NCT05518383 2022-08-26

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 4 Recruiting
300 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡